Abstract
Medication guidelines are being incorporated into psychiatric care, and may serve multiple functions, including ensuring consistent quality care, minimizing or managing costs, integration of new treatments, and providing clinicians with information necessary to make informed clinical decisions. Methods of guideline development and the published guidelines for the medication treatment of bipolar disorder are briefly reviewed. Despite limited research on the clinical efficacy of using guidelines, they serve other useful functions such as prioritizing multiple treatment options and providing a framework for treatment. The future role of treatment algorithms in psychiatric practice will be determined, in part, by results of studies evaluating the clinical impact of their use.
Similar content being viewed by others
References and Recommended Reading
PalmerRH: Quality health care. JAMA 1996, 275:1851–1852.
Depression Guideline Panel:Clinical Practice Guideline 5. Depression in Primary Care: vol 1. InDetection and Diagnosis: AHCPR Publication 93-0550.Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
Depression Guideline Panel: Clinical Practice Guideline. Depression in Primary Care: vol 2. InTreatment of Major Depression: AHCPR Publication 93-0551. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
Rush AJ, Prien RF: From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? Psychopharmacol Bull 1995, 31:7–20.
Agency for Health Care Policy and Research: Using Clinical Practice Guidelines to Evaluate Quality of Care, vol 1: In Issues. AHCPR Publication Number 95-0045.Rockville, MD: US Department of Health and Human Services; 1995.
Agency for Health Care Policy and Research: Using Clinical Practice Guidelines to Evaluate Quality of Care, vol 2: In Methods. AHCPR Publication Number 95-0045. Rockville, MD: US Department of Health and Human Services; 1995b.
Gilbert DA, Altshuler KZ, Rago WV, et al.: Texas Medication Algorithm Project: definitions, rationale and methods to develop medication algorithms. J Clin Psychiatry 1998, 59:345–351.
Regier DA, Myers JK, Kramer M, et al.: The NIMH epidemiologic catchment area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984, 41:934–941.
Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994, 51:8–19.
Kashner TM, Suppes T, Rush AJ, Altshuler, A: Measuring use of outpatient mental health services: a comparison of self reports and provider records. Evaluation and Program Planning 2000, in press
Suppes T, Habermacher E, Potter W: Treatment Algorithms and Guidelines for Bipolar Disorder. InTreatment Algorithms in Clinical Psychopharmacology. Edited byJobsonK,SteinD, and FawcettJ.New York: John Wiley & Sons; 2000. This book chapter is an excellent resource that discusses interest in and development of treatment guidelines for bipolar disorder, benefits and disadvantages of their utilization, and the potential impact they may have on future treatment of bipolar disorder.
Dennehy EB, Suppes T: Medication algorithms for bipolar disorder. J Pract Psychiatry Behav Health 1999, 5:142–152. This article is geared toward practitioners. After briefly reviewing the history of guideline development and adoption in this area, the contents of all published guidelines for treatment of bipolar disorder are summarized. Areas of agreement and disagreement are discussed, and best options for treatment decisions are summarized.
Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP: Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry 1994, 164:208–214.
Freeman MP, Stoll AL: Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998, 155:12–21.
Denicoff KD, Smith-Jackson EE, Disney ER, et al.: Comparative prophylactic efficacy of lithium, cabamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997, 58:470–478.
Freeman MP, Suppes T, Keck PE: The use of combination medications in bipolar disorder: a review of safety and efficacy. Harvard Rev Psychiatry 1999, in submission.
Ketter TA, Pazzaglia PJ, Post RM: Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. J Clin Psychopharmacol 1992, 12:276–281.
Keck PE Jr, McElroy SL, Vuckovic A, Friedman LM: Combined valproate and carbamazepine treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992, 4:319–322.
Solomon DA, Keitner GI, Miller IW, et al.: Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 1995, 56:5–13.
Tohen M, Castillo J, Pope HGJ, Herbstein J: Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. J Clin Psychopharmacol 1994, 14:67–70.
Keck PE Jr., McElroy SL, Nemeroff CB: Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992, 4:395–405.
Kramlinger KG, Post RM: Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatr Scand 1989, 79:378–385.
Suppes T, Calabrese JR, Mitchell PB, et al.: Algorithms for the treatment of bipolar, manic-depressive illness. Psychopharmacol Bull 1995, 31:469–474.
American Psychiatric Association: Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry 1994, 151(Suppl):12.
Sachs GS, Printz DJ, Kahn DA, et al.: The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med 2000, 1–104. This citation is one of the most recently developed comprehensive guidelines for treatment of bipolar disorder. It is an excellent resource for the clinician, and contains much supplemental documentation regarding treatment options, level of evidence, and multifaceted management of patients with bipolar disorder.
Rush AJ, Crismon ML, Toprac MG, et al.: Consensus guidelines in the treatment of major depressive disorder. J Clin Psych 1998, 59(Suppl 20):73–84.
Kusumakar V, Yatham LN: The treatment of bipolar disorder: review of the literature, guidelines, and options: introduction. Can J Psychiatry 1997, 42(Suppl 2):67S-68S.
Kusumakar V, Yatham LN, Haslam DRS, et al.: The treatment of bipolar disorder: review of the literature, guidelines, and options: the foundations of effective management of bipolar disorder. Can J Psychiatry 1997, 42(Suppl 2):69S-73S.
Parikh SV, Kusumakar V, Haslam DRS, et al.: The treatment of bipolar disorder: review of the literature, guidelines, and options: psychosocial interventions as an adjunct to pharmacotherapy in bipolar disorder. Can J Psychiatry 1997, 42(Suppl 2):74S-78S.
Kusumakar V, Yatham LN, Haslam DRS, et al.: The treatment of bipolar disorder: review of the literature, guidelines, and options: treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 1997, 42(Suppl 2):79S-86S.
Yatham LN, Kusumakar V, Parikh SV, et al.: The treatment of bipolar disorder: review of the literature, guidelines, and options: bipolar depression: treatment options. Can J Psychiatry 1997, 42(Suppl 2):87S-91S.
Sharma V, Yatham LN, Haslam DRS, et al.: The treatment of bipolar disorder: review of the literature, guidelines, and options: continuation and prophylactic treatment of bipolar disorder. Can J Psychiatry 1997, 42(Suppl 2):92S-100S.
JobsonK: International Psychopharmacology Algorithm Project: algorithms in psychopharmacology. Int J Psychiatry Clin Pract 1997, 1:S3-S8.
Goodwin GM, Bourgeois ML, Conti L, et al.: Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatry Clin Pract 1997, 1:S9-S12.
Bauer MS, Callahan AM, Jampala C, et al.: Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 1999 60:9–21. This citation is one of the most recently developed comprehensive guidelines for treatment of bipolar disorder. It is an excellent resource for the clinician, and contains much supplemental documentation regarding treatment options, level of evidence, and multifaceted management of patients with bipolar disorder.
Rush AJ, Crismon ML, Toprac MG, et al.: Implementing guidelines and systems of care: experiences with the Texas Medication Algorithm Project (TMAP). J Pract Psychiatry Behav Health 1999, 5:75–86.
Shon SP, Toprac MG, Crismon ML, Rush AJ: Strategies for implementing psychiatric medication algorithms in the public sector. J Pract Psychiatry Behav Health 1999, 5:32–36.
Regier DA, Farmer ME, Rae DS, et al.: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511–2518.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dennehy, E.B. Guidelines for treatment of bipolar disorder. Curr Psychiatry Rep 2, 316–321 (2000). https://doi.org/10.1007/s11920-000-0074-7
Issue Date:
DOI: https://doi.org/10.1007/s11920-000-0074-7